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Purpose: To determine whether the removal of the inner wall of Schlemm’s canal (external 
trabeculectomy) improves the effectiveness of a modified method of deep sclerectomy (DS), 
which we will call “reversed” deep sclerectomy (RDS).
Materials and method: We conducted a prospective study of two groups of patients. Group A 
included 22 eyes of 18 patients with open angle glaucoma (OAG) under maximum medical 
treatment, which underwent RDS – a modified method of performing DS – with the removal 
of the inner wall of Schlemm’s canal (external trabeculectomy) and without using any implant. 
Group B included 20 eyes of 17 patients which had undergone RDS alone. Demographic 
and tonometric data of patients of Group A revealed no significant difference from data of 
patients in Group B. A mean follow up period for Group A was 22.8 months and for Group B 
was 23.4 months. The outcome of the operations was termed a total success when intraocular 
pressure (IOP) was ,21 mmHg postoperatively, without additional treatment, relative success 
when IOP was ,21 mmHg with additional treatment and a total failure when IOP . 21 mmHg 
with medical treatment.
Results: Total success was achieved in 18/22 eyes (81.8%) for Group A and in 8/20 eyes 
(40%) for Group B (P , 0.05). Relative success was achieved in 22/22 (100%) for Group 
A and in 17/20 eyes (85%) in Group B (P = NS). Total failure occurred in 0/22 eyes (0%) in 
Group A and in 3/20 (15%) eyes in Group B (P = NS). The mean postoperative IOP in Group 
A was 13.5 ± 2.8 mmHg with a reduction of 12.4 ± 4.6 mmHg (48.1%) and in Group B mean 
postoperative IOP was 18 ± 4.3 mmHg with a reduction of 6.2 ± 6.9 (25.6%) (P , 0.001). 
Mean drug reduction postoperatively was 3.2 ± 0.9 drugs in Group A and 1.7 ± 1.2 in Group B 
(P , 0.001).
Conclusion: In the follow up time during which the two groups were under study (12–36 months), 
the removal of the inner wall of Schlemm’s canal while performing RDS proves an important 
factor in improving its effectiveness.
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Introduction
Deep sclerectomy (DS) with or without collagen implant1–9 is a non-penetrating, 
  tunneling surgical procedure for the treatment of medically uncontrolled open-angle 
glaucoma (OAG). It was designed to lower the risk of classic trabeculectomy 
complications.10–12
Tissues in the angle of the anterior chamber are believed by most researchers to be 
responsible for the main aqueous outflow resistance in glaucoma.13–15 During classic 
DS, after the removal of the external layers of Schlemm’s canal, its inner wall and the 
juxtacanalicular meshwork are left intact. Through acquired past experience and taking  Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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into consideration the modifications suggested, DS has been 
proven to be a reliable alternative to trabeculectomy.9,16–32 
However a significant disadvantage to DS is its long learn-
ing curve.5,33–35
We applied a modified DS, called “reversed” deep sclerec-
tomy (RDS). This RDS procedure did not remove additional 
tissue compared to classic DS.36 The idea of Zimmerman 
and colleagues37 to remove the inner wall of Schlemm’s 
canal with the adjacent trabecular layers, but without the 
juxtacanalicular tissue (tissue that constitutes a site of great 
outflow resistance) during the procedure of nonperforating 
tunneling (external trabeculectomy) was a clever one. Most 
authors agree that external trabeculectomy significantly low-
ers intraocular pressure (IOP) and greatly improves outflow 
in protruding eyes of both pigs and humans.9,38,39
The aim of our study is to compare the postoperative 
results of RDS with external trabeculectomy to RDS alone 
(without external trabeculectomy) in patients with medi-
cally uncontrolled OAG, in order to determine whether the 
external trabeculectomy improves the effectiveness of RDS 
in IOP regulation.
Materials and methods
Group A includes 22 eyes of 18 patients with uncontrolled 
OAG, despite receiving maximum tolerable medical treat-
ment, which underwent RDS with the removal of the inner 
wall of Schlemm’s canal and the external layers of the trabe-
cular meshwork with external trabeculectomy. We excluded 
eyes with perforation of the anterior chamber during this 
procedure (RDS and external trabeculectomy).
Group B includes 20 eyes of 17 patients with uncontrolled 
OAG, despite receiving maximum tolerable medical treat-
ment, that have undergone RDS without the removal of the 
external layers of trabecular meshwork and the inner wall 
of Schlemm’s canal (without external trabeculectomy). The 
selection of patients was made in such a way that demographic 
and tonometric preoperative data could be compared to that of 
group A (Table 1). Furthermore the selection was undertaken 
by an individual who was unaware of the postoperative course 
of the cases. All patients of both groups gave their consent 
after being informed of the procedures. We excluded eyes with 
perforation of the anterior chamber during the RDS.
The mean preoperative IOP in group A was 25.8 ± 
3.6 mmHg and in group B 24.2 ± 5.1 mmHg, a difference 
that is not statistically significant. The average number of 
preoperative antiglaucoma drugs for group A was 3.5 ± 0.7 
and for group B it was 2.8 ± 0.5; the difference being statis-
tically significant (P , 0.001). The average follow-up time 
was similar for both groups (22.8 ± 7.8 months for group A 
and 23.4 ± 8.9 months for group B).
For all patients of both groups, uncontrolled OAG was 
defined as measurement of IOP $ 21 mmHg and progres-
sion of optic neuropathy and visual field defects, despite 
maximum tolerable antiglaucoma therapy. The criteria for the 
diagnosis of OAG were according to the American Academy 
of Ophthalmology (Glaucoma).40
Excluded from the study were patients with acute primary 
glaucoma, secondary glaucoma, patients with previous eye 
surgery or laser trabeculoplasty as well as patients with 
myopia or hypermetropia greater than 3D or astigmatism 
more than 1D that could potentially affect our measure-
ments. Patients with pseudo-exfoliation glaucoma were 
included in the study. Preoperative examination included 
best corrected visual acuity, slitlamp biomicroscopy, gonios-
copy, Goldmann applanation tonometry, static perimetry 
using the Humphrey perimeter 24-2 (Humphrey Inc, San 
Leandro, California, USA), ultrasound pachymetry (Pacline; 
OPTICON 2000 SpA, Rome, Italy) and dilated pupil deter-
mination of cup/disc ratio. All patients of both groups were 
Greek Caucasian and had OAG of the same severity. Their 
central corneal thickness was with within the normal range 
(group A: 549.32 ± 29.4 µm, group B: 550.24 ± 26.2 µm) 
Table 1 Demographic data of 35 patients (42 eyes)
Group A Group B P value
Number of patients 18 17
Males/females 10/8 9/8
Age, years, mean (SD) 68.3 (7.7) 71.7 (7.1) NS
Number of eyes with open-angle glaucoma 22 20
Eyes with primary open-angle glaucoma 12 12
Eyes with pseudo-exfoliation glaucoma 10 (45.4%) 8 (40%)
IOP (mmHg) (preoperatively), mean (SD) 25.8 (3.6) 24.2 (5.1) NS
Number of antiglaucoma drugs (preoperatively), mean (SD) 3.5 (0.7) 2.8 (0.5) ,0.01
Follow-up time (postoperatively), (range 12–36 months), mean (SD) 22.8 (7.8) 23.4 (8.9) NS
Abbreviations: SD, standard deviation; IOP, Intraocular pressure.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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and their blood pressure was controlled (with or without 
drug administration).
Postoperatively patients were examined in the first ten 
days and again up to one month postoperatively, while fur-
ther examinations on most patients were performed at the 
Glaucoma Department of the University Eye Clinic or by 
medical attendants at their area of residence. The examination 
included best corrected visual acuity, slitlamp biomicroscopy 
and Goldmann applanation tonometry. Visual fields were 
performed every 6 months or annually at the Glaucoma 
department of our clinic.
All the ophthalmologists at the follow-up examinations were 
blinded to the fact that these patients were study patients.
“Reversed” deep sclerectomy
DS without implant was applied in a modified manner. It is 
a classic DS where prior to the formation of a deep scleral 
petal, Schlemm’s canal is opened. The operations in both 
groups were performed by the same surgeon (PK) using 
retrobulbar anesthesia. A 4-0 silk suture is placed onto the 
superior rectus muscle of the operated eye followed by a 
  dissection at the limbus at the 10th and 2nd hour where there 
are no large penetrating vessels.
In greater detail, a scleral flap of 4 × 5 mm is prepared 
between 10th and 2nd hours. The preparation of the flap is 
then extended reaching 1 mm from the stroma of the cornea. 
With the aid of a thin diamond knife, we seek Schlemm’s 
canal and perform a radial incision at the limbus where the 
sclera changes into the darker area of the trabeculum. A guide 
for locating Schlemm’s canal is the horizontal white fibres of 
the scleral spur that lie at the borderline of the white sclera. 
Just anterior of these fibers lies Schlemm’s canal from which 
after perforation aqueous humor wells up.
Following the location of Schlemm’s canal, a radial 
incision is extended to the opposite side of the quadrangle, 
dividing it into two equal parts. The depth of the incision 
must not extend to the full thickness of the scleral stroma in 
order to avoid reaching the ciliary body.
Two parallel incisions are then made on both sides of 
the initial incision near the oblique sides of the quadrangle, 
extending towards the limbus only, so as to facilitate the 
preparation of the anterior part of the deep scleral flap.
At this point, we perforate the anterior chamber in order 
to cause hypotony and thus separate the inner and outer layer 
of Schlemm’s canal. Using very thin Vannas scissors, we 
excise the outer layer of Schlemm’s canal by inserting one 
leg of the scissors into the canal from the main opening, first 
on one and then on the other side.
With the aid of a triangular sponge, we detach the anterior 
segment of the scleral flap from the underlying trabeculum. 
The detachment is extended beyond Schwalbe Iine towards 
Descemet’s membrane, which we reveal at an area of about 
0.5–1 mm.2 With the aid of small scissors, we excise this 
anterior segment of the deep scleral stroma.
The posterior part of the deep scleral stroma is separated 
into two parts (petals), with the aid of a diamond knife, leaving 
a very thin layer of the sclera corresponding to the ciliary body. 
One petal is then prepared up to its middle, while the remainder 
is undermined in order to fold the latter inside. In the same 
manner we fold the other petal, too. Due to the   folding of the 
two petals, a triangular endoscleral space is formed. Next, we 
suture the superficial scleral flap placing two 10–0 sutures at 
the corners of the quadrangle. A small quantity of viscoelastic 
fluid is placed under the superficial flap. The conjunctiva is 
sutured at the limbus using two 8–0 sutures.
If, during the preparation of the anterior segment of the 
deep scleral flap (towards Descemet’s membrane), a small 
perforation of the trabeculo – Descemet’s membrane was 
to take place, without iris prolapse, the operation would be 
continued. If the perforation is greater and the iris prolapses, 
then a peripheral iridectomy may be performed to allow 
continuation of the case without converting it to a typical 
trabeculectomy.
“Reversed” deep sclerectomy  
and external trabeculectomy
After formation of the deep scleral flap in the manner 
described, with the aid of a thin 15° knife, we separate, going 
towards the end of Schlemm’s canal, the outer layers of the 
corneoscleral meshwork which includes the inner wall of 
the Schlemm’s canal. Using a thin pincer Bonn, we peel the 
whole part of the inner wall of Schlemm’s canal with the 
external layers of corneoscleral meshwork without perforat-
ing the anterior chamber. Then, using 10–0 nylon sutures, we 
suture the superficial scleral flap at the two corners. A small 
quantity of viscoelastic fluid is injected into the endoscleral 
space or parathalamus41,42 and finally an 8–0 silk suture is 
placed on the conjunctiva at the limbus.
Postoperatively, patients from both groups were treated 
with a combination of corticosteroid and antibiotic eye 
drops; 1–2 three times daily for three weeks. After the first 
week, Tropicamide eye drops were added 1–2 drops three 
times daily.
During the postoperative follow-up examination, if 
an encapsulated bleb formed or if signs of fibrosis of the 
bleb were evident with a simultaneous elevation of IOP,  Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
560
Kitsos et al
we   perform subconjunctival injections of 5-Fluorouracil 
(5-Fu) (0.1 ml of a 5-Fu 50 mg/ml solution) once daily for 
5 days.
The results of the operation were considered from us a 
“total success” if the IOP did not exceed 21 mmHg without 
administration of glaucoma drugs or without 5-Fu subcon-
junctival injections. The procedure was consider a “relative 
success” if IOP was maintained below 21 mmHg with the aid 
of glaucoma drugs or/and 5-Fu subconjunctival injections, 
and the procedure was considered a “total failure” if the IOP 
exceeded 21 mmHg with drugs or/and 5-Fu subconjunctival 
injections.
Statistical analysis
Results were statistically compared with the aid of χ2-test for 
qualitative parameters and Student’s t-test for quantitative 
parameters. Kaplan–Meier curves were calculated from the 
moment of operation until the last followup or until register-
ing as a failure.
Results
In both Group A and Group B, cases were included only 
if there was no perforation of the anterior chamber. We 
excluded the eyes, of both groups, with perforation during 
the procedure. The average follow-up time was 22.8 months 
(standard deviation [SD] = 7.8) for group A and 23.4 months 
(SD = 8.9) for group B. In Table 2, we present the postopera-
tive results of our study.
In Group A, “total success” was achieved in 18 out of 
22 eyes (81.8%) at the time of the last follow-up examina-
tion. The remaining 4 eyes achieved IOP # 21 mmHg with 
glaucoma therapy, and/or 5-Fu subconjunctival injections; 
so that “relative success” was 100%. The mean postopera-
tive IOP was 13.5 ± 2.8 mmHg with a mean reduction of 
12.4 ± 4.6 mmHg (48%). The mean number of glaucoma 
drugs used preoperatively was 3.5 ± 0.7 (Table 1), and was 
reduced to 0.2 ± 0.5 postoperatively (mean reduction in drugs 
3.2 ± 0.9). In 2 eyes 5-Fu subconjunctival injections were 
performed in “relative success”.
In Group B, out of 20 eyes, we achieved “total success” 
in 8 eyes (40%) and “relative success” (85%) in 9 eyes upon 
adding glaucoma drugs. In 3 eyes there was “total failure” 
and IOP was lowered only after performing trabeculectomy. 
The mean postoperative IOP was 18 ± 4.3 mmHg and mean 
reduction 6.2 ± 6.9 mmHg (25.6%). The average number of 
glaucoma drugs used preoperatively was 2.8 ± 0.5 (Table 1) 
which was reduced postoperatively to 1.1 ± 1.2 (mean reduc-
tion of 1.7 ± 1.2). In 4 eyes, 5Fu subconjunctival injections 
were performed in 3 eyes with “relative success” and in one 
eye with “total failure”.
The progression of optic nerve damage and visual field 
defects were stable with regards to eyes of both groups with 
total or relative success at follow-up. Regarding bleb forma-
tion in both groups, bleb morphology was low and diffuse. 
We did not note enlarged blebs or complications regarding 
inflammation during the follow-up period.
In 3 eyes of group B, during the first three days post-
operatively, a relative shallowing of the anterior chamber 
with hypotony was observed, which was quickly reversed. 
Similarly, shallowing was noticed in 8 eyes of group A.
In Figure 1 and in Table 3, we present the conduct of 
the mean postoperative IOP and during the entire follow-up 
period for both groups comparatively.
In Figure 2, two Kaplan–Meier curves are shown. In the 
curve corresponding to RDS, the percentage of total and 
relative success in 36 months fell to 83%, while in the curve 
corresponding to RDS and external trabeculectomy, the per-
centage still remains at 100%. The two were compared with 
the testing of log-rank and the difference was statistically 
significant (P = 0.08).
Discussion
It has become accepted by most authors that the main 
aqueous outflow resistance is detected in the inner wall of 
Table 2 Postoperative results (42 eyes of 35 patients)
Group A (22 eyes) Group B (20 eyes) P value
Total success 18/22 (81.8%) 8/20 (40%) ,0.05
Relative success 22/22 (100%) 17/20 (85%) NS
Total failure 0/22 (0%) 3/20 (15%) NS
Postoperative IOP (mmHg), mean (SD) 13.5 (2.8) 18 (4.3) ,0.001
IOP decrease (mmHg), mean (SD) 12.4 (4.6) (48.1%) 6.2 (6.9) (25.6%) ,0.001
Number of antiglaucoma drugs postoperatively, mean (SD) 0.2 (0.5) 1.1 (0.9) ,0.001
Decrease in number of antiglaucoma drugs, mean (SD) 3.2 (0.9) 1.7 (1.2) ,0.001
Use of 5-FU (number of eyes) 2 (9.1%) 4 (20%) ,0.001
Abbreviations: SD, standard deviation; IOP, Intraocular pressure; 5-FU, 5-Fluorouracil.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Schlemm’s canal and in the juxtacanalicular meshwork.13–15 
The removal of a part of the trabeculum in a glaucoma 
operation would normally dramatically reduce the aqueous 
outflow resistance.
It was Zimmerman and colleagues37 who first developed 
the idea of removing the inner wall of Schlemm’s canal with 
the external layers of the trabeculum, calling their method, 
non-penetrating trabeculectomy. However, this is in fact a 
deep sclerectomy with the removal of the inner wall of the 
Schlemm’s canal and the outer part of the trabeculum (exter-
nal trabeculectomy).9,35
Nowadays, many surgeons, combine DS with or without 
an implant with external trabeculectomy.2,3,6–9,17–25,43
Hamard and colleagues44 studying the histology of the 
inner wall of Schlemm’s canal removed during the external 
trabeculectomy, proved that it contained the inner wall of 
Schlemm’s canal rather than the juxtacanalicular meshwork 
and a very thin layer consisting of the external parts of the 
corneoscleral meshwork. The diaphragm therefore which 
separates the anterior chamber from the endoscleral space 
or parathalamus consists of a uveal trabecular meshwork and 
the largest part of the inner corneoscleral meshwork.
In one experimental study on protruding eyes of both pigs 
and humans, Rossier and colleagues38 observed that external 
trabeculectomy increased rather easily aqueous outflow. 
In our study, we compare the postoperative results of eyes in 
groups A and B, consisting of cases of medically uncontrolled 
POAG. In group A consisting of 22 eyes of 18 patients, we 
applied RDS by removing the inner wall of Schlemm’s canal 
(external trabeculectomy). In group B consisting of 20 eyes 
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Figure 1 Mean IOP preoperatively and postoperatively in regular intervals during follow up in RDS and RDS and external trabeculectomy.
Abbreviations: IOP, intraocular pressure; RDS, reversed deep sclerectomy.
Table 3 Mean (SD) of IOP preoperatively and postoperatively at regular intervals during follow-up
IOP preoperative1 IOP postoperative1
1 day 7 day 1 day 3 day 6 day 12 day 18 day 24 day 36 day
Group A 25.8 (3.6) 8.8 (5.8) 8.9 (4.3) 12.2 (2.5) 14.1 (3.1) 16.9 (7.8) 14.1 (2.4) 14.2 (2.9) 11.5 (2.0) 15.7 (4.0)
Group B 24.2 (5.1) 13.5 (7.3) 14.2 (6.0) 19.0 (6.7) 17.5 (3.4) 18.0 (2.9) 18.1 (4.9) 18.5 (3.4) 16.1 (2.6) 17.4 (1.5)
Notes: 1The values are measured as mmHg.
Abbreviations: SD, standard deviation; IOP, intraocular pressure. Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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of 17 patients, patients were operated using RDS method. As 
seen in Table 1, there is no statistically significant difference 
between groups A and B regarding the patients’ age, the pre-
operative mean IOP and the average postoperative follow-up 
time. On the contrary, patients from group A used more 
glaucoma drugs preoperatively than patients from group B 
(3.5 ± 0.7 compared to 2.8 ± 0.5, P , 0.01). With regards to 
postoperative tonometric results (Tables 2 and 4), we observed 
a total success in Group A in 81.8% of cases, compared to 
40% in group B (P , 0.05). Similarly, the mean postoperative 
IOP for group A was 13.5 mmHg with a mean reduction of 
12.4 mmHg (48%) compared to 18 ± 4.3 mmHg and mean 
reduction of 6.2 mmHg (25.6%) in group B. Both these differ-
ences showed a significant statistical difference (P , 0,001). 
Even for group A, the average number of   anti-glaucoma drugs 
used   postoperatively is clearly less (0.2 ± 0.5 as compared to 
1.1 ± 0.9, P , 0.001). The postoperative statistically signifi-
cant difference in the mean IOP and the percentage decrease 
in group A (as mentioned above) may well be explained by the 
fact that during an external trabeculectomy there is a greater 
increase of aqueous outflow through the remaining membrane 
to enter the parathalamus or endoscleral space. This occurs 
normally, because during the external trabeculectomy, together 
with the inner wall of Schlemm’s canal and the meshwork, 
a limited number of external flaps from the corneoscleral 
trabeculum are removed.
Rossier and colleagues38 proved experimentally that the 
simple aqueous outflow of protruding human eyes is increased 
from 0.24 ± 0.08 mL/min/mmHg to 6.33 ± 6.67 mL/min/
mmHg after external trabeculectomy; an increase that is 
0
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Figure 2 Kaplan–Meier curves for over time effectiveness of RDS and RDS and external trabeculectomy.
Abbreviation: RDS, reversed deep sclerectomy.
Table 4 Tonometry data and antiglaucoma drug treatment (preoperatively and postoperatively)
Preoperative Postoperative P value
Group A
IOP (mmHg), mean (SD) 25.8 (3.6) 13.5 (2.8) ,0.001
Decrease IOP (mmHg), mean (SD) 12.4 (4.6) (48.1%)
Number of antiglaucoma drugs, mean (SD) 3.5 (0.7) 0.2 (0.5) ,0.001
Group B
IOP (mmHg), mean (SD) 24.2 (5.1) 18 (4.3) ,0.01
Decrease IOP (mmHg), mean (SD) 6.2 (6.9) (25.6%)
Number of antiglaucoma drugs, mean (SD) 2.8 (0.5) 1.1 (0.9) ,0.01
Abbreviations: SD, standard deviation; IOP, intraocular pressure.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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26 times greater. This increase can be explained by the fact 
that during external trabeculectomy, the diaphragm through 
the aqueous outflow consists only of the uveal meshwork 
and the largest inner part of the corneoscleral trabeculum 
meshwork.
From the comparison between two Kaplan–Meier curves, 
there is a difference between both methods which does not 
prove to be statistically significant (P , 0.08).
In relation to the postoperative IOP during the follow-up 
time (Figure 1 and Table 3), it is noted that cases that under-
went external trabeculectomy show a greater hypotony in 
the first postoperative week when compared to cases hav-
ing undergone RDS (average 8.9 ± 4.3 mmHg compared 
to 14.2 ± 6.0). The explanation for this observation may 
be that during an external trabeculectomy, the diaphragm 
which separates the anterior chamber from the parathalamus 
becomes much thinner.
It may be concluded from the cases which were studied 
for an average of 24 months (12–36 months), that RDS in 
combination with external trabeculectomy has better IOP 
regulation results than RDS alone.
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